The endocrine manifestations of adults with spinal muscular atrophy
Muscle & Nerve · 2024
DOI: 10.1002/mus.28275 ↗Kurz gefasst
Fachartikel in der Zeitschrift Muscle & Nerve, 2024. Verfasst von Matej Rakusa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Diabetes and Metabolic Disease, University Medical Centre Ljubljana, Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Muscular Atrophy, Spinal, Body Composition. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction/Aims Changes in body composition in patients with spinal muscular atrophy (SMA) can cause endocrine abnormalities that are insufficiently studied in adults. We aimed to assess the endocrine profile in a cohort of adults with SMA. Second, we compared body composition and endocrine profiles between nonambulatory and ambulatory patients and between different types of SMA.
Methods
The cross‐sectional study included 29 SMA patients (18 [62.1%] males and 11 [37.9%] females) of median age 44 (IQR 30–51.5) years with type 2, 3, or 4. Body composition was measured by bioimpedance. Morning blood samples were drawn for glycated hemoglobin (HbA1c), lipid profile, testosterone, cortisol, and insulin‐like growth factor‐1 (IGF‐1). Blood glucose, insulin, and beta‐hydroxybutyrate (BHB) were measured during a 75 g oral glucose tolerance test. The homeostatic model assessment for insulin resistance index was calculated.
Results
In total, 75.9% of patients had increased fat mass (FM), with 51.7% having an increase despite normal body mass index. Ambulation was the most important discriminating factor of body composition. 93.1% of patients had metabolic abnormalities, including hyperglycemia, insulin resistance, and dyslipidemia. Increased BHB, a marker of ketosis, was present in more than a third of patients. Functional hypogonadism was present in half of male patients. Testosterone and IGF‐1 negatively correlated with FM.
Discussion
Adult patients with SMA had abnormal body composition and highly prevalent metabolic disturbances that might increase cardiometabolic risk. Because treatments have modified the course of SMA, it is important to investigate whether these observations translate into clinically relevant outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Diabetes and Metabolic Disease, University Medical Centre Ljubljana, Ljubljana, Slovenia.
- Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
- Institute of Clinical Neurophysiology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
- Department of Neurology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
- Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
- Radiology Institute, University Medical Centre Ljubljana, Ljubljana, Slovenia.
ORCID-Profile: Matej Rakusa, Blaž Koritnik, Žiga Snoj
Zitieren
APA
Rakusa, M., Koritnik, B., Leonardis, L., Goricar, K., Rudolf, T., Firbas, D., Snoj, Ž., & Jensterle, M. (2024). The endocrine manifestations of adults with spinal muscular atrophy. Muscle & Nerve. https://doi.org/10.1002/mus.28275
Vancouver
Rakusa M, Koritnik B, Leonardis L, Goricar K, Rudolf T, Firbas D, et al. The endocrine manifestations of adults with spinal muscular atrophy. Muscle & Nerve. 2024. doi:10.1002/mus.28275
BibTeX
@article{Rakusa2024,
author = {Rakusa, Matej and Koritnik, Blaž and Leonardis, Lea and Goricar, Katja and Rudolf, Tjasa and Firbas, Dejan and Snoj, Žiga and Jensterle, Mojca},
title = {The endocrine manifestations of adults with spinal muscular atrophy},
journal = {Muscle & Nerve},
year = {2024},
doi = {10.1002/mus.28275}
}
EUVIMED